Wolverine Trading’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Wolverine Trading’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,700	Closed	-$348K	–	6096
2024 Q4	$348K	Buy	+6,700	New	+$329K	﹤0.01%	3853
2022 Q2	–	Sell	-2,300	Closed	-$209K	–	5969
2022 Q1	$209K	Buy	+2,300	New	+$188K	﹤0.01%	4377
2021 Q4	–	Sell	-13,500	Closed	-$1.06M	–	7066
2021 Q3	$1.06M	Buy	13,500 +8,200	+155%	+$689K	﹤0.01%	2922
2021 Q2	$498K	Buy	5,300 +500	+10%	+$48.5K	﹤0.01%	3691
2021 Q1	$485K	Buy	+4,800	New	+$498K	﹤0.01%	3747

Other funds holding NARI

SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TCWM

Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return

Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Wolverine Trading's NARI Position: Q2 2022 in Review

Wolverine Trading sold out of Inari Medical, Inc. Common Stock (NARI) in Q2 2022, closing a stake of 5,283 shares — an estimated $380K sold.

Wolverine Trading first reported a position in NARI in Q1 2021 and held it in 5 quarters. The position peaked at $601K in Q4 2021. 227 funds tracked by Wall St. Rank hold NARI as of Q2 2022.

Wolverine Trading reported no remaining Inari Medical, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Wolverine Trading sold 5,283 Inari Medical, Inc. Common Stock shares in Q2 2022, an estimated $380K.
Wolverine Trading first reported a position in Inari Medical, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
Wolverine Trading's Inari Medical, Inc. Common Stock position peaked at $601K in Q4 2021.
227 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2022.

Based on Wolverine Trading's 13F filing for Q2 2022, filed 15 Aug 2022.